Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis

Clinical trial NCT01221402 · COMPLETED

Trial details

NCT number: NCT01221402
Sponsor: North Texas Veterans Healthcare System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis Intermediate Saphenous Vein Graft Lesions

Start date: 2010-10-01
Primary completion: 2014-10-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.